News

The latest news, announcements, and medical updates from CBeam

cbeam-primary
Pulmera Establishes U.S. Headquarters at The Pearl Innovation District in Charlotte, North Carolina
Charlotte, NC, July 29, 2026 — Pulmera, an emerging medical technology company developing next-generation intraoperative imaging solutions, today announced the establishment of its U.S. headquarters at Connect Labs by Wexford, located within The Pearl, Charlotte’s innovation district. This strategic move positions Pulmera within a transformative hub for healthcare innovation and scientific advancement, providing access to leading scientific resources, entrepreneurial support and opportunities...
cbeam-primary
FDA Grants 510(k) Clearance for Pulmera’s CBeam™ 3D Imaging Platform
CBeam by Pulmera transforms existing C-arm infrastructure into scalable intraoperative3D imaging PALO ALTO, Calif., June 2, 2026 — Pulmera, an emerging medical technology company developing next-generation intraoperative imaging solutions, today announced that it has received U.S. Food and Drug Administration 510(k) clearance for its CBeam™ 3D imaging platform. CBeam is designed to transform conventional 2D surgical C-arms into intraoperative 3D imaging systems, helping surgical teams visualize...
Kevin-McGann-Picture
Kevin McGann to Present Pulmera’s C-Beam Technology at LSI USA ’26
We are pleased to announce that Kevin McGann, CEO of Pulmera, has been selected to present at LSI USA ’26, taking place March 16–20, 2026 at the Waldorf Astoria in Monarch Beach, California. Kevin will present on March 19th at 3:00 PM, where he will introduce Pulmera and share insights into our proprietary C-Beam™ technology, along with our strategic pathway toward commercialization in 2026. The LSI conference brings together leading innovators, investors, and executives in the...